ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 1904

$659K Total Retail Price of All Prescriptions

Rank: 293 out of 1904

416 Patients Receiving at Least One Drug in Part D
76% Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

21% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 505 311 89 S3 1 2
FUROSEMIDE 351 299 70 2 7
AMLODIPINE BESYLATE 344 266 52 3 6
LISINOPRIL 331 269 61 4 3
OXYCODONE HCL 316 71 33 S2 5 99
OMEPRAZOLE 310 242 58 6 5
LEVOTHYROXINE SODIUM 297 231 47 7 1
SIMVASTATIN 269 247 36 8 4
SERTRALINE HCL 269 231 37 8 25
METFORMIN HCL 266 174 50 10 9
ALPRAZOLAM 249 121 51 B 11 15
HYDROCHLOROTHIAZIDE 242 179 40 12 11
METOPROLOL TARTRATE 225 173 45 13 12
PRAVASTATIN SODIUM 207 131 38 14 10
ATORVASTATIN CALCIUM 179 144 32 15 8
CLOPIDOGREL 174 150 26 16 20
WARFARIN SODIUM 169 164* 20 17 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 160 90 34 18 23
LOSARTAN POTASSIUM 155 138 26 19 21
NAMENDA 153 153 18 20 28
DONEPEZIL HCL 152 152 26 21 32
POTASSIUM CHLORIDE 147 142* 26 22 17
TAMSULOSIN HCL 142 122 21 23 26
LORAZEPAM 134 129* 18 B 24 36
ALBUTEROL SULFATE 133 121 22 25 127
GABAPENTIN 129 84 25 26 13
MELOXICAM 127 97 22 27 29
MIRTAZAPINE 121 116* 18 28 57
IPRATROPIUM-ALBUTEROL 119 114* 15 29 110
GLIPIZIDE 118 80 19 30 73
OXYCONTIN 113 13 11 S2 31 150
LOSARTAN-HYDROCHLOROTHIAZIDE 111 80 18 32 48
CARVEDILOL 103 91 26 33 24
METOPROLOL SUCCINATE 100 84 19 34 16
TRAZODONE HCL 100 72 15 34 47
CYMBALTA 98 87 11 36 34
OXYCODONE HCL-ACETAMINOPHEN 92 18 16 S2 37 81
CITALOPRAM HBR 91 53 15 38 22
ZOLPIDEM TARTRATE 91 54 19 38 30
ADVAIR DISKUS 91 51 12 38 56
DIOVAN 88 <11 <11 41 61
GLIPIZIDE ER 87 61 16 42 104
LANTUS 85 67 19 43 55
MORPHINE SULFATE ER 85 20 14 S2 43 109
IBUPROFEN 81 48 25 45 102
FAMOTIDINE* 81 65 14 45 67
PREDNISONE 81 62 28 45 40
CLONAZEPAM 79 27 15 B 48 44
POLYETHYLENE GLYCOL 3350 79 74* 21 48 50
SPIRIVA 73 44 12 50 62
FLUOXETINE HCL 73 38 15 50 41
ATENOLOL 71 57 16 52 19
ALENDRONATE SODIUM 70 70 11 53 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 54 32 54 84
TRAMADOL HCL 68 48 15 54 18
JANUVIA 67 62* 11 56 69
PROAIR HFA 67 31 18 56 45
CLONIDINE HCL 65 <11 <11 58 66
ISOSORBIDE MONONITRATE ER 64 <11 <11 59 64
CRESTOR 62 42 13 60 33
FENTANYL 62 42 14 S2 60 74
DEXILANT 61 <11 <11 62 198
OXYCODONE-ACETAMINOPHEN 61 20 13 S2 62 97
NEXIUM 61 <11 <11 62 37
AZITHROMYCIN 60 45 51 65 46
FINASTERIDE 57 <11 <11 66 136
LYRICA 57 39 11 66 88
LACTULOSE 56 <11 <11 68 184
FLUTICASONE PROPIONATE 55 22 19 69 49
TOPIRAMATE 52 <11 <11 70 147
SPIRONOLACTONE 52 36 12 70 60
LOVASTATIN 51 <11 <11 72 54
TRIAMTERENE-HCTZ 51 <11 <11 72 52
ESCITALOPRAM OXALATE 50 36 17 74 39
RANITIDINE HCL 50 <11 <11 74 43
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.